Publication list
2024
Kolostyák, Z.,
Bojcsuk, D.,
Baksa, V.,
Máthéné Szigeti, Z.,
Bene, K.,
Czimmerer, Z.,
Botó, P.,
Fadel, L.,
Póliska, S.,
Halász, L.,
Tzerpos, P.,
Berger, W.,
Villabona-Rueda, A.,
Varga, Z.,
Kovács, T.,
Patsalos, A.,
Pap, A.,
Vámosi, G.,
Bai, P.,
Dezső, B.,
Spite, M.,
D'Alessio,, F.,
Szatmári, I.,
Nagy, L.:
EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, 2024.
Journal metrics:
D1 Medicine (miscellaneous) (2023)
2023
Rehó, B.,
Fadel, L.,
Brázda, P.,
Benziane, A.,
Hegedűs, É.,
Sen, P.,
Gadella, T.,
Tóth, K.,
Nagy, L.,
Vámosi, G.:
Agonist-controlled competition of RAR and VDR nuclear receptors for heterodimerization with RXR is manifested in their DNA-binding.
J. Biol. Chem. 299 (2), 1-16, 2023.
Journal metrics:
Q1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
2022
Bosire, R.,
Fadel, L.,
Mocsár, G.,
Nánási, P.,
Sen, P.,
Sharma, A.,
Naseem, M.,
Kovács, A.,
Kugel, J.,
Kroemer, G.,
Vámosi, G.,
Szabó, G.:
Doxorubicin impacts chromatin binding of HMGB1, Histone H1 and retinoic acid receptor.
Sci. Rep. 12 (1), 1-14, 2022.
2020
Fadel, L.,
Rehó, B.,
Volkó, J.,
Bojcsuk, D.,
Kolostyák, Z.,
Nagy, G.,
Müller, G.,
Simándi, Z.,
Hegedűs, É.,
Szabó, G.,
Tóth, K.,
Nagy, L.,
Vámosi, G.:
Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor.
J. Biol. Chem. 295 (29), 10045-10061, 2020.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
Rehó, B.,
Lau, L.,
Mocsár, G.,
Müller, G.,
Fadel, L.,
Brázda, P.,
Nagy, L.,
Tóth, K.,
Vámosi, G.:
Simultaneous Mapping of Molecular Proximity and Comobility Reveals Agonist-Enhanced Dimerization and DNA Binding of Nuclear Receptors.
Anal. Chem. 92 (2), 2207-2215, 2020.
updated: 2025-01-26, 01:46
